Demoor L, Boutillon C, Fievet C, Vanloo B, Baert J, Rosseneu M, Fruchart J C, Tartar A
Service de Recherche sur les Lipoprotéines, Institut Pasteur, Lille, France.
Eur J Biochem. 1996 Jul 1;239(1):74-84. doi: 10.1111/j.1432-1033.1996.0074u.x.
Amphipathic helical repeats are considered as the structural units of numerous apolipoproteins and have been described as being responsible for the interaction of apolipoproteins with phospholipids in high-density lipoproteins (HDL). Furthermore, apolipoproteins, and especially apolipoprotein AI (apoAI), are involved in various biological functions of these circulating particles in plasma. Studies with synthetic peptides corresponding to domains of the apoAI sequence have however shown that short 39-residue fragments do not interact strongly enough with phospholipids to generate particles that correctly mimic the physico-chemical properties of HDL reconstituted with native apoAI [Vanloo, B., Demoor, L., Boutillon, C., Lins, L., Baert, J., Fruchart, J. C., Tartar, A. & Rosseneu, M. (1995) Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids, J. Lipid Res. 36, 1686-1696.]. Here we show that synthetic branched multimeric peptides, often used as carriers for the design of synthetic vaccines (multiple-antigen peptides), can be used to mimic the physiochemical properties of apoAI in HDL. This type of molecule is obtained by using a small core matrix of Lys residues bearing radially branched synthetic peptides as dendritic arms. We compared the lipid-binding capacities and the structural properties of a linear peptide corresponding to residues 145-183 of apoAI [apoAI-(145-183)-peptide] with those of two multimeric peptides consisting respectively of three [trimeric apoAI-(145-183)] and four copies [tetrameric apoAI-(145-183)] of the selected sequence, branched on a covalent core matrix. This paper provides evidence for the increased abilities of the multimeric peptides to associate with phospholipids compared with the short linear peptides. Moreover, the trimeric apoAI-(145-183) peptide was most efficient in mimicking the physico-chemical and structural properties of native apoAI in reconstituted HDL. As tools adequate to unravel the structure/function relationship of separate apolipoprotein domains are still missing, these multimeric peptides might constitute an alternative approach to linear peptides which are poor mimetics and to protein mutants which are difficult to produce and only provide information about the total sequence.
两亲性螺旋重复序列被认为是众多载脂蛋白的结构单元,并且被描述为负责载脂蛋白与高密度脂蛋白(HDL)中磷脂的相互作用。此外,载脂蛋白,尤其是载脂蛋白AI(apoAI),参与了血浆中这些循环颗粒的各种生物学功能。然而,对与apoAI序列结构域相对应的合成肽的研究表明,39个氨基酸残基的短片段与磷脂的相互作用不够强烈,无法产生能够正确模拟用天然apoAI重构的HDL物理化学性质的颗粒[Vanloo, B., Demoor, L., Boutillon, C., Lins, L., Baert, J., Fruchart, J. C., Tartar, A. & Rosseneu, M. (1995) Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids, J. Lipid Res. 36, 1686 - 1696.]。在此我们表明,常用于合成疫苗设计的载体(多抗原肽)——合成支链多聚肽,可用于模拟HDL中apoAI的物理化学性质。这类分子是通过使用一个由赖氨酸残基构成的小核心基质获得的,该基质带有呈放射状分支的合成肽作为树状臂。我们将与apoAI第145 - 183位残基相对应的线性肽[apoAI-(145 - 183)-肽]的脂质结合能力和结构特性,与分别由选定序列的三个拷贝[三聚体apoAI-(145 - 183)]和四个拷贝[四聚体apoAI-(145 - 183)]在共价核心基质上分支构成的两种多聚肽的脂质结合能力和结构特性进行了比较。本文提供了证据,证明与短线性肽相比,多聚肽与磷脂结合的能力增强。此外,三聚体apoAI-(145 - 183)肽在模拟重构HDL中天然apoAI的物理化学和结构特性方面最为有效。由于仍然缺乏足以阐明单个载脂蛋白结构域结构/功能关系的工具,这些多聚肽可能构成一种替代方法,以替代模拟效果不佳的线性肽以及难以生产且仅提供有关完整序列信息的蛋白质突变体。